Case report: Uterus sarcoma associated with a microangiopathic hemolytic anemia. A review;Anemie hemolytique microangiopathique associee a un sarcome uterin: Rapport d'un cas. Revue de la litterature

Revue de Medecine Interne

Volumn 17, Issue 9, 1996, Pages 749-753

  Tsatsaris, V ^a   Lotz, J P ^a   Parrot, A ^a   Andre T ^a   Lafont, B ^a   Bouleuc, C ^a   Antoine, M ^a   Izrael, V ^a  

^a HÔPITAL TENON   (France)

Author keywords

chemotherapy; hemolytic anemia; intra alveolar hemorrhage; metastatic sarcoma; microangiopathic hemolytic anemia

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DACTINOMYCIN; VINCRISTINE; VINDESINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HEMOLYTIC ANEMIA; HUMAN; SARCOMA; UTERUS CANCER; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; LEIOMYOSARCOMA; LUNG TUMOR; METASTASIS; MIDDLE AGED; REVIEW; SYNDROME;

ANEMIA, HEMOLYTIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEIOMYOSARCOMA; LUNG NEOPLASMS; MIDDLE AGED; SYNDROME; UTERINE NEOPLASMS;

EID: 0030246928     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/0248-8663(96)83703-9     Document Type: Article

References (23)

1. Bell W. Thrombotic thrombocytopenic purpura. JAMA 1991;265:91-3
2. Murgo AJ. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 1987;24:161-7
3. Gulati SC, Sordillo P, Kempin S et al. Microangiopathic hemolytic anemia observed after treatement of epidermoid carcinoma with mitomycin C and 5-fluorouracil. Cancer 1980;1: 2252-7
4. Jolivet J, Giroux L, Laurin S et al. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome. Cancer Treat Rep 1983;67:429-34
5. Jackson AM, Rose BD, Graff LG et al. Thrombotic Microangiopathy and renal failure associated with antineoplastic chemotherapy. Ann Intern Med 1984;101:41-4
6. Doll DC, Ringenberg QS, Yarbro JW. Vascular toxicity associated with antineoplastic agents. J Clin Oncol 1986;4:1405-17
7. Walker RW, Rosenblum MK, Kempin SJ. Carboplatin-associated thrombotic microangiopathic hemolytic anemia. Cancer 1989;64:1017-20
8. Gradishar WJ, Vokes EE, Ni K et al. Chemotherapy-related hemolytic-uremic syndrome after the treatement of head and neck cancer. Cancer 1990;66:1914-8
9. Angiola G, Bloss JD, DiSaia PJ. Hemolytic-uremic syndrome associated with neoadjuvant chemotherapy in the treatement of advanced cervical cancer. Gynecol Oncol 1990;39:214-7
10. Bodensteiner DC, Doolittle GC. Adverse haematological complications of anticancer drugs. Drug Safety 1993;8:213-24
11. Goodnight S. Bleeding and intra-vascular clotting in malignancy. A review. Ann N Y Acad Sci 1974;230:271-88
12. Antman KH. Skarin AT. Mayer RJ. Microangiopathic hemolytic anemia and cancer. A review. Medecine 1979;5:377-84
13. Rauch AE, Tartaglia AP, Kaufman B et al. RBC fragmentation and thymoma. Arch Intern Med 1984;144:1280-2
14. Claycomb CL, Berkovic M. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatement of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: Report of a case. J Am Osteopath Assoc 1986;8:499-503
15. Bell WR, Braine HG, Ness PM. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N Engl J Med 1991;6:398-403
16. Rock GA, Shumak KH, Buskard NA. Comparison of plasma exchange with plasma infusion in the treatement of thrombotic thrombocytopenic purpura. N Engl J Med 1991;6:393-7
17. Grem JL, Merrit JA, Carbone PP. Treatement of mitomycin-associated microangiopathic hemolytic anemia witn vincristine. Arch Intern Med 1986;146:566-8
18. Gutterman LA, Stevenson TD. Treatement of thrombotic thrombocytopenic purpura with vincristine. JAMA 1982;247:1433-6
19. Hug V, Burgess A, Blumenshein G et al. Effect of cyclophosphamide on the mitomycin-induced syndrome of thrombotic thrombocytopenic purpura. Cancer Treat Rep 1985;69:565-6
20. Korec S, Schein PS, Smith FP. Treatement of cancer-associated hemolytic and uremic syndrome with staphylococcal protein A immunoperfusion. J Clin Oncol 1986;4:210-5
21. Chow S, Roscoe J, Cattran DC. Plasmapheresis and antiplatelet agent in the treatement of the hemolytic uremic syndrome secondary to mitomycin. Am J Kidney Dis 1986;7:407-12
22. Snow RM, Miller WC, Rice DL et al. Respiratory failure in cancer patients. JAMA 1979;241:2039-42
23. Holdsworth S, Boyce N. Thomson NM. The clinical spectrum of acute glomerulonephritis and lung haemorrhage. QJM 1985;216:75-86